Finding significance: New perspectives in variant classification of the RAD51 regulators, BRCA2 and beyond

DNA Repair (Amst). 2023 Aug 19;130:103563. doi: 10.1016/j.dnarep.2023.103563. Online ahead of print.ABSTRACTFor many individuals harboring a variant of uncertain functional significance (VUS) in a homologous recombination (HR) gene, their risk of developing breast and ovarian cancer is unknown. Integral to the process of HR are BRCA1 and regulators of the central HR protein, RAD51, including BRCA2, PALB2, RAD51C and RAD51D. Due to advancements in sequencing technology and the continued expansion of cancer screening panels, the number of VUS identified in these genes has risen significantly. Standard practices for variant classification utilize different types of predictive, population, phenotypic, allelic and functional evidence. While variant analysis is improving, there remains a struggle to keep up with demand. Understanding the effects of an HR variant can aid in preventative care and is critical for developing an effective cancer treatment plan. In this review, we discuss current perspectives in the classification of variants in the breast and ovarian cancer genes BRCA1, BRCA2, PALB2, RAD51C and RAD51D.PMID:37651978 | DOI:10.1016/j.dnarep.2023.103563
Source: DNA Repair - Category: Genetics & Stem Cells Authors: Source Type: research